Skip to main content
. 2019 Nov 15;26(8):1239–1250. doi: 10.1093/ibd/izz267

TABLE 1.

Patient Characteristics in Propensity-Matched RISK-PROKIIDS Comparator Groups

Characteristic Standard Care Early Intervention With Biologics P
n = 237, No. (%) n = 123, No. (%)
Sex, female 75 (31.6) 41 (33.3) 0.837
Age at diagnosis, mean (SD), y 12.27 (2.65) 12.28 (2.70) 0.964
Albumin, mean (SD), g/dL 3.46 (0.59) 3.43 (0.62) 0.717
Height Z score, mean (SD) –0.38 (1.08) –0.45 (1.21) 0.577
Family history of IBD 0.164
 No 1st-degree relative 185 (78.1) 107 (87.0)
 One 1st-degree relative 41 (17.3) 14 (11.4)
 Two 1st-degree relatives 3 (1.3) 0 (0.0)
 Unknown 8 (3.4) 2 (1.6)
Ethnicity 0.335
 Caucasian 176 (74.3) 88 (71.5)
 African 21 (8.9) 12 (9.8)
 Mixed 18 (7.6) 7 (5.7)
 Other 10 (4.2) 9 (7.3)
 Unknown 12 (5.1) 7 (5.7)
Presence of perianal disease 0.048*
 No 169 (71.3) 72 (58.5)
 Yes 66 (27.8) 50 (40.7)
 Unknown 2 (0.8) 1 (0.8)
Disease activity at diagnosis (Physician Global Assessment) 0.235
 None 3 (1.3) 0 (0.0)
 Mild 59 (24.9) 23 (18.7)
 Moderate 121 (51.1) 74 (60.2)
 Severe 54 (22.8) 26 (21.1)
Disease location 0.962
 No L1–L3 disease 0 (0.4) 1 (0.8)
 L1 33 (13.9) 17 (13.8)
 L2 48 (20.3) 23 (18.7)
 L3 136 (57.4) 70 (56.9)
 Unknown 19 (8.0) 12 (9.8)

Chi-square test, t test, and Kruskal-Wallis rank-sum tests were used for comparisons between groups depending on continuous or noncontinuous variables.

*P < 0.05.